| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |